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c o n c i s e c o m m u n i c a t i o n
Nosocomial Outbreak of Pseudomonas
aeruginosa Endophthalmitis
I. Mateos, MD; R. Valencia, MD; M. J. Torres, PhD;
A. Cantos, MD; M. Conde, MD; J. Aznar, MD, PhD
We describe an outbreak of nosocomial endophthalmitis due to a
common source, which was determined to be trypan blue solution
prepared in the hospital’s pharmacy service. We assume that viable
bacteria probably gained access to the trypan blue stock solution
during cooling after autoclaving. The temporal cluster of Pseudo-
monas aeruginosa endophthalmitis was readily perceived on the basis
of clinical and microbiological findings, and an exogenous source
of contamination was unequivocally identified by means of DNA
fingerprinting.
Infect Control Hosp Epidemiol 2006; 27:1249-1251
Pseudomonas aeruginosa is a gram-negative bacillus com-
monly found in soil and moist environments and capable of
surviving and growing in nutrient-poor water. P. aeruginosa
often colonizes the lungs of patients with cystic fibrosis and
has emerged as an important opportunistic pathogen in hos-
pitalized and immunocompromised patients.1 Small hospital
outbreaks of infection with this pathogen are frequent and
are usually traceable to a single contaminated source.
The most serious complication of ocular surgery remains
postoperative endophthalmitis.2-4 Endophthalmitis involves
inflammation of the intraocular cavities and its adjacent
structures and can result in severe complications, such as a
loss of visual acuity. The incidence of postoperative endo-
phthalmitis is low, less than 0.5%, although reported rates
vary from 0.08 to 1%.5-7 These complications are caused by
patients’ own cutaneous flora, such as Staphylococcus epider-
midis, Staphylococcus aureus, and Streptococcus species. Gram-
negative bacteria are implicated in fewer than 20% of cases
of endophthalmitis,6 and most of these cases are caused by
Pseudomonas species and Enterobacteriaceae. However, stud-
ies have reported air, intraocular contact lenses, irrigation
fluid, and surgery equipment as exogenous sources of post-
surgical endophthalmitis.6,7
We describe a nosocomial outbreak of P. aeruginosa en-
dophthalmitis following cataract extraction that occurred be-
tween November 2003 and February 2004 at the ophthal-
mology service of our hospital, and we report the results of
an epidemiological investigation.
methods
In January 2004, two cases of postoperative P. aeruginosa
endophthalmitis after cataract extraction were reported. A
nosocomial endophthalmitis outbreak was suspected, which
prompted us to carry out an epidemiological and microbi-
ological investigation to identify the source and the route of
infection. A retrospective and prospective search for cases was
done. A case was defined as endophthalmitis in any patient
who had had ophthalmic surgery at the hospital between
November 2003 and February 2004; a case was considered
confirmed if P. aeruginosa was isolated and otherwise sus-
pected. The patient’s files were reviewed, and the intraoper-
ative and postoperative outcomes were analyzed. The epi-
demiological survey was focused on 2 areas: review of the
surgical procedure and the sterility of the surgical areas, as
well as the patient’s exposure to a common source of con-
tamination. The staff members were interviewed about sur-
gical procedures and sterilization methods, and the preop-
erative and preparation areas were inspected. Vitreous fluid
and anterior-chamber fluid specimens obtained from the case
patients were cultured. Samples of various medications, oph-
thalmic solutions (including trypan blue solution), intraoc-
ular lenses, surgical equipment, and selected environmental
sites were cultured by conventional microbiological methods.
All the isolates were identified on the basis of their ap-
pearance on Gram staining, colony morphology, motility, and
cytochrome oxidase production. Final identification and sus-
ceptibility testing were performed with the semiautomatic
MicroScan WalkAway system (Dade Behring). Additionally,
all the trypan blue solution samples were inoculated into
blood culture bottles and cultured in an automatic culture
system for 6 days (Bactec 9240; Roche Diagnostics).
To determine the relatedness of the isolates of P. aeruginosa,
we used a repetitive-element polymerase chain reaction assay
to obtain the DNA fingerprints of the strains.8,9
results
During the epidemic period, 12 (1.3%) of 913 patients who
underwent cataract surgery received a diagnosis of endoph-
thalmitis. We identified 6 suspected cases of P. aeruginosa
endophthalmitis, but we only confirmed 4 cases. The first 2
confirmed cases, in women aged 58 years and 61 years, oc-
curred in January 2004, and the other 2 cases, in a man aged
65 years and a woman aged 68 years, were diagnosed in
February 2004.
All 4 patients with confirmed cases developed signs and
symptoms of endophthalmitis 24 hours after the surgical pro-
cedure. In 1 case, the evolution was good with antibiotic
treatment; keratoplasty was required in 1 case, and in 2 cases
enucleation was performed.
In all 6 cases, trypan blue solution was used for staining
the anterior lens capsule to facilitate the cataract surgery.10,11
Only 0.5 mL of trypan blue solution was used per procedure,
and it was washed off with saline solution during the surgery.
The trypan blue solution was mixed in the pharmacy service
of our hospital after reconstitution of a commercial trypan
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Vial 1   
Vial 2   
Vial 3   
Vial 4   
Trypan blue stock solution   
Autoclave water   
figure Repetitive-element polymerase chain reaction patterns
for the Pseudomonas aeruginosa isolates studied. Lanes 1-5 and 7-9,
clinical isolates (duplicated run); lanes 10-11 and 13-14, trypan blue
isolates; lanes 6 and 12, 100-bp molecular size markers; lanes 15-16,
autoclave water isolates.
blue powder with phosphate buffer solution. This reconsti-
tuted solution was sterilized by autoclave and dispensed asep-
tically in commercial sterile vials. The vials of solution were
sent to the operating theater and stored at room temperature.
It was intended that the solution be passed through a filter
with 0.22-mm pores before use.
Samples were collected from 4 vials of trypan blue solution
(1 sample from each different vial) used during cataract sur-
gery that were in the surgical area and from the trypan blue
stock solution in the central pharmacy. After 24 hours of
incubation, P. aeruginosa was isolated from all trypan blue
solution samples (Table). Phenotypic identification and an-
timicrobial susceptibility patterns suggested that the P. aeru-
ginosa isolates from clinical samples and the isolates from the
trypan blue solution vials had the same biotype and antibio-
type. These results prompted us to focus on the trypan blue
solution as the common exogenous source of contamination.
We decided to culture all the components of the trypan
blue stock solution, before and after the sterilization process,
as well as water from the autoclave. All the samples were
culture negative for pathogens, except for samples of auto-
clave water, which yielded P. aeruginosa, Stenotrophomonas
maltophilia, and Alcaligenes xylosoxidans (Table).
The repetitive-element polymerase chain reaction assay
demonstrated that all P. aeruginosa strains isolated from clin-
ical samples and trypan blue solution samples had the same
DNA fingerprint (Figure).
discussion
In our hospital, the prevalence of endophthalmitis following
cataract surgery was 0.8% in the year before the outbreak,
but during the epidemic period it was 1.3%. The attack rate
for P. aeruginosa postoperative endophthalmitis during this
outbreak was 0.65%. Many cases of P. aeruginosa postoper-
ative endophthalmitis have been reported, and this micro-
organism has been described as a cause of endophthalmitis
with rapid progression and a poor visual prognosis.3
In the epidemic cases described in the literature, the source
of infection has been the saline solution used for moisten-
ing the cornea during surgery, the indomethacin ophthalmic
preparation, or implanted contaminated lenses.3,4,6,7 In the
outbreak we describe, we suspected that endophthalmitis was
caused by contaminated trypan blue solution, because this
solution was used in all cases, and because Morel et al.12
previously described contamination of trypan blue with
Bukholderia cepacia in a cornea bank. We found P. aeruginosa
in the water of the autoclave, in the sterilized trypan blue
stock solution, and in the 4 trypan blue solution vials used
in surgery, as well as in the 4 vitreous fluid samples obtained
from all patients with a diagnosis of postcataract-surgery
endophthalmitis.
The repetitive-element polymerase chain reaction assay
demonstrated that all clinical P. aeruginosa isolates and all
trypan blue isolates had the same DNA fingerprint. This find-
ing allowed us to conclude that this outbreak was caused by
an exogenous common source, which was the trypan blue
solution prepared in the hospital’s pharmacy service. We as-
sume that viable bacteria probably gained access to the try-
pan blue stock solution during cooling after autoclaving, as
has been described elsewhere,13 although this could not be
confirmed because the P. aeruginosa strains isolated from au-
toclave water and the clinical isolates had different repetitive-
element polymerase chain reaction fingerprints. This dis-
crepancy probably occurred because the autoclave water
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samples were cultured 1 month after the first case of en-
dophthalmitis was diagnosed. The isolation of 3 species of
gram-negative, nonfermentative bacilli, including P. aerugi-
nosa, from the autoclave’s water allows us to assume that
contamination could take place during autoclaving. Addi-
tionally, an inquiry revealed that the trypan blue solution in
vials prepared in the surgery service from trypan blue stock
solution was not passed through a filter with 0.22-mm pores,
as it should have been.
Thus, this outbreak occurred because of 2 incorrect pro-
cedures: defective autoclave processing and failure to filter
the trypan blue solution before use. After this study and recall
of the trypan blue solution used, no new cases of endo-
phthalmitis occurred.
The temporal cluster of P. aeruginosa endophthalmitis cases
was readily perceived on the basis of clinical and microbio-
logical findings, and an exogenous source of contamination
was unequivocally identified by means of the DNA finger-
printing of the strains involved.
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the Red Española de Investigación en Patologı́a Infecciosa (Instituto de Salud
San Carlos III, CO3/14).
From the Service of Clinical Microbiology (I.M., A.C., J.A.), the Service
of Preventive Medicine (R.V., M.C.) and the University of Seville (M.J.T.,
J.A.), University Hospitals Virgen del Rocı́o, Seville, Spain.
Address reprint requests to J. Aznar, MD, PhD, Servicio de Microbiologı́a,
Hospitales Universitarios Virgen del Rocı́o, Avda. Manuel Siurot, s/n 41013
Sevilla, Spain (javier.aznar.sspa@juntadeandalucia.es).
Received July 18, 2005; accepted December 16, 2005; electronically pub-
lished October 4, 2006.
 2006 by The Society for Healthcare Epidemiology of America. All rights
reserved. 0899-823X/2006/2711-0018$15.00.
references
1. Pier GB, Ramphal R. Pseudomonas aeruginosa. In: Mandell GL, Bennett
JE, Dolin R, eds. Mandell, Douglas and Bennett’s Principles and Practice of
Infectious Diseases. 6th ed. New York: Churchill Livingston; 2005:2587-2611
2. Busbee BG. Advances in knowledge and treatment: an update on en-
dophthalmitis. Current Opin Ophthalmol 2004; 15:232-237.
3. Callegan MC, Engelbert M, Parke DW II, Jet BD, Gilmore MS. Bacterial
endophthalmitis: epidemiology, therapeutics, and bacterium-host inter-
actions. Clin Microbiol Rev 2002; 15:111-124.
4. Cruciani M, Malena M, Amalfitano G, Monti P, Bonomi L. Molecular
epidemiology in a cluster of cases of postoperative Pseudomonas aeru-
ginosa endophthalmitis. Clin Infect Dis 1998; 26:330-333.
5. Hanscom TA. Postoperative endophthalmitis. Clin Infect Dis 2004; 38:
542-546.
6. Taban M, Behrens A, Newcomb RL, Nobe MY, Saedi G, Sweet PM et
al. Acute endophtalmitis following cataract surgery: a systematic review
of the literature. Arch Ophthalmol 2005; 123:613-20.
7. Swaddiwudhipong W, Linlawan P, Prasantong R, Kiphati R, Wongwat-
charapaiboon P. A report of an outbreak of postoperative endophthal-
mitis. J Med Assoc Thai 2000; 83:902-907.
8. Martin-Lozano D, Cisneros JM, Becerril B, et al. Comparison of a re-
petitive extragenic palindromic sequence-based PCR method and clinical
and microbiological methods for determining strain sources in cases of
nosocomial Acinetobacter baumannii bacteriemia. J Clin Microbiol 2002;
40:4571-4575.
9. Woods CR, Versalovic J, Koeuth T, Lupski JR. Whole-cell repetitive el-
ement sequence–based polymerase chain reaction allows rapid assess-
ment of clonal relationships of bacterial isolates. J Clin Microbiol 1993;
31:1927-1931.
10. Laureano JS, Corroneo MT. Crystalline lens capsule staining with trypan
blue. J Cataract Refract Surg 2004; 30:2046-9.
11. Saini JS, Jain AK, Sukhija J, Gupta P, Saroha V. Anterior and posterior
capsulorhexis in pediatric cataract surgery with or without trypan blue
dye: randomized prospective clinical study. J Cataract Refract Surg 2003;
29:1732-7.
12. Morel PC, Roubi N, Talon DR, Betrand X. Contamination of trypan
blue with Burkholderia cepacia in a cornea bank. Infect Control Hosp
Epidemiol 2003; 24:198-201.
13. Doit C, Simon AM, Ferroni A, et al. Outbreak of Bukholderia cepacia
bacteraemia in a pediatric hospital due to contamination of lipid emul-
sion stoppers. J Clin Microbiol 2004; 42:2227-2230.
This content downloaded from 150.214.182.30 on Tue, 13 Jun 2017 10:25:49 UTC
All use subject to http://about.jstor.org/terms
